Loading…

Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization

Saved in:

Bibliographic Details
Published in:	Clinical Chemistry 2021-02, Vol.67 (2), p.434-435
Main Authors:	Lefferts, Joel A, Allen, Samantha F, Steinmetz, Heather B, Tsongalis, Gregory J
Format:	Article
Language:	English
Subjects:	Asymptomatic Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - virology COVID-19 Testing - methods Disease control Disease transmission Epidemiology FDA approval Genomes Humans Infections Letter to the Editor Medical laboratories Pandemics Public health Reverse Transcriptase Polymerase Chain Reaction - methods RNA-directed DNA polymerase SARS-CoV-2 - isolation & purification Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 United States United States Food and Drug Administration Viral infections
Citations:	Items that this one cites Items that cite this one
Online Access:	Request full text
Tags:	Add Tag No Tags, Be the first to tag this record!